Metabolic status in children and its transitions during childhood and adolescence-the IDEFICS/I.Family study.

BACKGROUND This study aimed to investigate metabolic status in children and its transitions into adolescence. METHODS The analysis was based on 6768 children who participated in the European IDEFICS/I.Family cohort (T0 2007/2008, T1 2009/2010 and/or T3 2013/2014; mean ages: 6.6, 8.4 and 12.0 years, respectively) and provided at least two measurements of waist circumference, blood pressure, blood glucose and lipids over time. Latent transition analysis was used to identify groups with similar metabolic status and to estimate transition probabilities. RESULTS The best-fitting model identified five latent groups: (i) metabolically healthy (61.5%; probability for group membership at T0); (ii) abdominal obesity (15.9%); (iii) hypertension (7.0%); (iv) dyslipidaemia (9.0%); and (v) several metabolic syndrome (MetS) components (6.6%). The probability of metabolically healthy children at T0 remaining healthy at T1 was 86.6%; when transitioning from T1 to T3, it was 90.1%. Metabolically healthy children further had a 6.7% probability of developing abdominal obesity at T1. Children with abdominal obesity at T0 had an 18.5% probability of developing several metabolic syndrome (MetS) components at T1. The subgroup with dyslipidaemia at T0 had the highest chances of becoming metabolically healthy at T1 (32.4%) or at T3 (35.1%). Only a minor proportion of children showing several MetS components at T0 were classified as healthy at follow-up; 99.8% and 88.3% remained in the group with several disorders at T1 and T3, respectively. CONCLUSIONS Our study identified five distinct metabolic statuses in children and adolescents. Although lipid disturbances seem to be quite reversible, abdominal obesity is likely to be followed by further metabolic disturbances.

[1]  S. Vento,et al.  Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients , 2020, Frontiers in Medicine.

[2]  A. Darzi,et al.  Fate of the metabolically healthy obese—is this term a misnomer? A study from the Clinical Practice Research Datalink , 2019, International Journal of Obesity.

[3]  H. Jang,et al.  Cardiovascular disease risk factor clustering in children and adolescents: a prospective cohort study , 2018, Archives of Disease in Childhood.

[4]  Ruizhi Zheng,et al.  The prevalence, metabolic risk and effects of lifestyle intervention for metabolically healthy obesity: a systematic review and meta-analysis , 2017, Medicine.

[5]  James D. Johnson,et al.  A causal role for hyperinsulinemia in obesity. , 2017, The Journal of endocrinology.

[6]  C. Phillips Metabolically healthy obesity across the life course: epidemiology, determinants, and implications , 2017, Annals of the New York Academy of Sciences.

[7]  I. Pigeot,et al.  The Transition from Childhood to Adolescence in European Children – How I.Family Extends the IDEFICS Cohort , 2017 .

[8]  R. Kelishadi,et al.  A systematic review on the prevalence of metabolic syndrome in Iranian children and adolescents , 2016, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[9]  C. Lewis,et al.  Transitions in Metabolic Risk and Long‐Term Cardiovascular Health: Coronary Artery Risk Development in Young Adults (CARDIA) Study , 2016, Journal of the American Heart Association.

[10]  E. Ramos,et al.  Trajectories of total and central adiposity throughout adolescence and cardiometabolic factors in early adulthood , 2016, International Journal of Obesity.

[11]  I. Hwang,et al.  Reference Values for The Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Non-High-Density Lipoprotein Cholesterol in Korean Children and Adolescents: The Korean National Health and Nutrition Examination Surveys 2007–2013 , 2016, Journal of atherosclerosis and thrombosis.

[12]  J. Thiery,et al.  Pediatric reference data of serum lipids and prevalence of dyslipidemia: Results from a population-based cohort in Germany. , 2016, Clinical biochemistry.

[13]  W. Verschuren,et al.  Trajectories of Metabolic Risk Factors and Biochemical Markers prior to the Onset of Cardiovascular Disease – The Doetinchem Cohort Study , 2016, PloS one.

[14]  M. Kelsey,et al.  Insulin Resistance of Puberty , 2016, Current Diabetes Reports.

[15]  Dan J Stein,et al.  Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[16]  D. Mutch,et al.  Molecular insights into the role of white adipose tissue in metabolically unhealthy normal weight and metabolically healthy obese individuals , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  M. Kivimaki,et al.  The natural course of healthy obesity over 20 years. , 2015, Journal of the American College of Cardiology.

[18]  I. Pigeot,et al.  Metabolic syndrome in young children: definitions and results of the IDEFICS study , 2014, International Journal of Obesity.

[19]  I Pigeot,et al.  Percentile reference values for anthropometric body composition indices in European children from the IDEFICS study , 2014, International Journal of Obesity.

[20]  W. Ahrens,et al.  Percentiles of fasting serum insulin, glucose, HbA1c and HOMA-IR in pre-pubertal normal weight European children from the IDEFICS cohort , 2014, International Journal of Obesity.

[21]  W. Ahrens,et al.  Blood lipids among young children in Europe: results from the European IDEFICS study , 2014, International Journal of Obesity.

[22]  W. Ahrens,et al.  Blood pressure reference values for European non-overweight school children: The IDEFICS study , 2014, International Journal of Obesity.

[23]  Myung‐Sook Choi,et al.  Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease , 2014, International journal of molecular sciences.

[24]  B. Klop,et al.  Dyslipidemia in Obesity: Mechanisms and Potential Targets , 2013, Nutrients.

[25]  Jianping Ye Mechanisms of insulin resistance in obesity , 2013, Frontiers of Medicine.

[26]  P. Yoon,et al.  Prevalence of Cardiovascular Disease Risk Factors Among US Adolescents, 1999−2008 , 2012, Pediatrics.

[27]  M. Czech,et al.  What causes the insulin resistance underlying obesity? , 2012, Current opinion in endocrinology, diabetes, and obesity.

[28]  I. Pigeot,et al.  The IDEFICS cohort: design, characteristics and participation in the baseline survey , 2011, International Journal of Obesity.

[29]  D. Lawlor,et al.  Association between general and central adiposity in childhood, and change in these, with cardiovascular risk factors in adolescence: prospective cohort study , 2010, BMJ : British Medical Journal.

[30]  S. Yanovski,et al.  The stability of metabolic syndrome in children and adolescents. , 2009, The Journal of clinical endocrinology and metabolism.

[31]  R. D'Agostino,et al.  Trajectories of Entering the Metabolic Syndrome: The Framingham Heart Study , 2009, Circulation.

[32]  Stephanie T. Lanza,et al.  A new SAS procedure for latent transition analysis: transitions in dating and sexual risk behavior. , 2008, Developmental psychology.

[33]  M. Lazar,et al.  Mechanisms of obesity-associated insulin resistance: many choices on the menu. , 2007, Genes & development.

[34]  S. Kahn,et al.  Mechanisms linking obesity to insulin resistance and type 2 diabetes , 2006, Nature.

[35]  J. Janosky,et al.  Longitudinal Study of Physiologic Insulin Resistance and Metabolic Changes of Puberty , 2006, Pediatric Research.

[36]  S. Srinivasan,et al.  Changes in Metabolic Syndrome Variables Since Childhood in Prehypertensive and Hypertensive Subjects: The Bogalusa Heart Study , 2006, Hypertension.

[37]  I. Pigeot,et al.  Understanding and preventing childhood obesity and related disorders--IDEFICS: a European multilevel epidemiological approach. , 2006, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[38]  J. Shaw,et al.  Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[39]  S. Srinivasan,et al.  Time-course of adiposity and fasting insulin from childhood to young adulthood in offspring of parents with coronary artery disease: the Bogalusa Heart Study. , 2002, Annals of epidemiology.

[40]  M. Lazar,et al.  Resistin and obesity-associated insulin resistance , 2002, Trends in Endocrinology & Metabolism.

[41]  M. Carskadon,et al.  A self-administered rating scale for pubertal development. , 1993, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[42]  Barnard Rj Effects of Life-style Modification on Serum Lipids , 1991 .

[43]  G. Reaven Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[44]  A. Engin,et al.  The Definition and Prevalence of Obesity and Metabolic Syndrome. , 2017, Advances in experimental medicine and biology.

[45]  L. Rossem,et al.  Overweight patterns throughout childhood and cardiometabolic markers in early adolescence , 2016, International Journal of Obesity.

[46]  T. Reinehr,et al.  Strong effect of pubertal status on metabolic health in obese children: a longitudinal study. , 2015, The Journal of clinical endocrinology and metabolism.

[47]  Y. Hata,et al.  Life-style and serum lipids and lipoproteins. , 2000, Journal of atherosclerosis and thrombosis.

[48]  S. Haffner,et al.  Development of the multiple metabolic syndrome: an epidemiologic perspective. , 1998, Epidemiologic reviews.

[49]  R. Barnard,et al.  Effects of life-style modification on serum lipids. , 1991, Archives of internal medicine.